Associate Professor, at Ningbo University, China.
Dr. Xiaoqin Zhang is a distinguished researcher in pharmacology, cell biology, and neurobiology at Ningbo University School of Medicine. Her expertise lies in understanding the pathogenesis and regulatory mechanisms behind cognitive impairments in neurological disorders like Alzheimer’s disease and schizophrenia. With a focus on neurobiological mechanisms of learning and memory, her work aims to inform targeted drug interventions to mitigate cognitive decline. Dr. Zhang has led multiple research projects, leveraging her extensive skills in molecular and cellular biology, whole-cell recordings, and behavioral assessments. Her commitment to advancing neuropharmacology is evident in her impactful publications and research contributions. 📚🔬
Profile
Scopus
ORCID
Education
- BS in Pharmaceutical Engineering: Dr. Zhang began her academic journey with a Bachelor’s degree from Wenzhou Medical University School of Pharmacy, gaining foundational knowledge in pharmaceutical sciences.
- MS in Pharmacology: She pursued a Master’s degree at Zhejiang University School of Medicine, where she developed her skills in pharmacology, focusing on molecular mechanisms in brain disorders.
- PhD in Neurobiology: Dr. Zhang completed her doctorate at Zhejiang University, where she specialized in neurobiology, researching the cognitive impairments associated with Alzheimer’s disease and schizophrenia. 🎓👩🔬
Experience
Dr. Zhang has a robust academic and research career with a focus on neurobiology and pharmacology. At Ningbo University, she plays a critical role as a researcher and mentor, guiding projects on cognitive impairments in neurological diseases. Her work spans administering grants, publishing influential studies, and advancing molecular and cellular research methodologies. Her expertise includes advanced techniques such as whole-cell recordings and behavioral assessments, which she applies to investigate synaptic plasticity and neural circuitry. Additionally, she collaborates on multidisciplinary projects that bridge neurobiology and pharmacological research. 🧪📊
Research Interests
Dr. Zhang’s research explores the pathogenesis and regulation of cognitive impairments in diseased brains, focusing on Alzheimer’s disease and schizophrenia. Her studies delve into neurobiological mechanisms underlying learning and memory, providing theoretical frameworks for neural circuit regulation. Her work includes investigations into synaptic plasticity, cognitive function, and targeted drug intervention. By examining cellular and molecular pathways, Dr. Zhang seeks to contribute to the development of therapeutic approaches that enhance cognitive health in patients with neurological disorders. 🧠💊
Awards
Dr. Zhang has received accolades for her pioneering research in neurobiology and pharmacology, including prestigious grants to support her work on cognitive impairment mechanisms in brain disorders. She has been honored for her impactful publications, particularly those exploring Alzheimer’s disease and schizophrenia, and her work is recognized by her peers for advancing the field of cognitive neuroscience. Her dedication to research excellence has positioned her as a key contributor in her field, and her work continues to garner support and recognition. 🏆🎖️
Publications
- Dong, Y., Fu, C., Zhang, T., et al. “Abnormal hippocampal neurogenesis and impaired social recognition memory in two neurodevelopmental models of schizophrenia.” FASEB J., 2024, 38(21)Link to publication
- Zhang, T., Liu, C., Zhong, N., et al. “Advances in the treatment of cognitive impairment in schizophrenia: targeting NMDA receptor pathways.” Int J Mol Sci., 2024, 25(19):10668.
Link to publication
- Shang, Q., Dong, Y., Zhang, X., et al. “Environmental enrichment improves recognition memory in adult mice following social isolation.” Molecular Neurobiology., 2024, 61(6):3742-3752.
Link to publication
- Zhang, X., Xu, L., Zhu, X., et al. “D-serine reconstitutes inhibitory control of pyramidal neurons in a schizophrenia model.” Nature Communications., 2023, 14(1):8255.
Link to publication
- Zhu, X., Luo, J., Zhang, X., et al. “PPARα in diet-induced risk avoidance impairment via hippocampal BDNF regulation.” Food & Function., 2023, 14(14):6541-6553.
Link to publication
Conclusion
Dr. Xiaoqin Zhang is highly qualified for the Research for Women Researcher Award. Her robust academic foundation, extensive publication record, and impactful research on cognitive impairment make her a deserving candidate. Her work in Alzheimer’s disease and schizophrenia aligns with pressing societal health challenges, and her expertise in both experimental and theoretical neurobiology offers substantial contributions to the field. Recognizing her with this award would not only acknowledge her achievements but also support her ongoing work with high potential for further impact.